KamiyaBiomedical
Kamiya Biomedical 是一家生命科学研究试剂生产商，Kamiya Biomedical开发用于**学的试剂、科研用elisa试剂、用于动物/临床前研究的ELISA试剂、抗体、生化试剂和其他研究用产品。其主要业务模式是提供高品质高性价比的产品。
Kamiya Biomedical主要产品线：抗体、生化试剂(如抑制剂)和各种指标检测试剂盒
for Chemistry Analyzers
Clinical Diagnostics & Research Use
  |
These products can be used on most chemistry analyzers, such as Roche, Cobas, Hitachi,beckman, Olympus, Siemens, Bayer, Dade, Abbott, Alfa Wassermann, and many more!
|
Kamiya Biomedical Company
|
|
|||||||||||
| AboutKAMIYA | ||||||||||||
Kamiya Biomedical Companywas founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality.KAMIYAis an independent American company that serves worldwide markets.  The company's first products were protein kinase inhibitors, staurosporine and its analog, K252a. Staurosporine was discovered in 1977 by Dr. Satoshi Ohmura who is a 2015 Nobel Prize winner. This was the first commercially available staurosporine. Today, staurosporine is one of the most popular research tools in life science research fields.Today,KAMIYA's life science product lines include thousands of human and animal biomarker assays for preclinical testing with one of the largest selections of ELISA kits in the world.KAMIYAcontinues to offer a variety of other life science research products including enzyme inhibitors and monoclonal / polyclonal antibodies for use in a variety of fields including apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes. In 1997,KAMIYAintroduced a full line of clinical diagnostic and research immunoassay products for lipid assessment, coagulation, inflammation, diabetes, nutritional assessment, and serum protein measurement based on immunoturbidimetric technology. TheK-ASSAYreagents were developed for use on standard chemistry analyzers, requiring no mixing, dissolving, or dilution of reagent or sample, at an exceptional value. Recently,KAMIYAhas introduced new innovativeK-ASSAYchemistry analyzer reagents for Insulin, D-Dimer, Factor XIII, Plasma FDP, Serum/Urine FDP, and Total IgE testing. KAMIYAnow has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S. We supply clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide. Look forKAMIYA BIOMEDICAL COMPANYto continue to offer the life science and medical communities with innovative and cutting edge laboratory research and diagnostic tools. |
Kamiya Biomedical Company
被 Kohji Kamiya 在1983年3月在加利福尼亚千橡市于1996年成立，并搬迁到西雅图，华盛顿。 我们公司的宗旨是提供生命科学和医学界的**实验室研究和*高质量的诊断工具。 KAMIYA 是服务于全球市场的独立的美国公司。
Since 1983 该公司的**个产品是蛋白激酶抑制剂，星形孢菌素及其类似物，K252a。星孢素是1977年由Satoshi Ohmura博士发现的，她是2015年诺贝尔奖获得者。这是**种商业上可获得的星形孢菌素。今天，星孢素是生命科学研究领域*受欢迎的研究工具之一。
今天， KAMIYA公司的生命科学产品线包括数以千计的人类和动物的生物标志物的检测 与ELISA试剂盒，在世界上*大的选择之一临床前试验。 KAMIYA 继续提供各种其他的生命科学研究的产品包括酶抑制剂和单克隆/多克隆抗体用于在各种领域，包括细胞凋亡，多药耐药性，氧化性/ DNA损伤和修复，骨生物学，癌症，心脏健康，炎症使用，应力，肥胖和糖尿病。
1997年， KAMIYA 推出了全系列的临床诊断和研究**产品的脂质评估，凝血，炎症，糖尿病， 营养评估和血清蛋白的测量基于**比浊技术。 在 K-ASSAY 试剂对标准的化学分析仪使用而开发的，无需混合，溶解，或试剂或样品稀释，物超所值。
近日，KAMIYA 已经推出胰岛素， D-二聚体， XIII因子，血浆FDP ，血/尿FDP和总IgE检测新的** K-ASSAY 化学分析仪试剂。
KAMIYA 现在有任何一家公司的液态血清蛋白**试剂在U.S.A.我们提供临床诊断试剂龙头医院，医疗中心， 临床实验室，临床参考实验室，研究机构，分销商和诊断仪世界各地的公司的*广泛的产品线。 我们提供临床诊断试剂，以全球优越的医院，医疗中心，临床实验室，临床参考实验室，研究机构，分销商和诊断仪公司。.
寻找Kamiya Biomedical Company继续提供生命科学和医学界的**和**实验室研究和诊断工具。
